Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Utah Medical Products, Inc.

Stage 2 · Advancing · week 38

As of Oct 22, 2026, Utah Medical Products is in Stage 2, the uptrend phase, now in week 38 (since Jan 27, 2026). It closed at $75.06, 2.1% below its 52-week high and above its 200-day average, which is rising.

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. More about the company

$75.06
+0.46% today
$238M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 18 in Medical Instruments & Supplies · #1 of 272 in Health Care

Is UTMD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 16w
S4 24w
S4 39w
S2 38w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 2w → S3 3w → S4 16w → S1 4w → S4 24w → S1 9w → S4 39w → S1 10w → S2 10w → S3 7w → S4 3w → S3 1w → S2 38w current
Total tracked: 166 weeks across 13 stage runs.

UTMD among Medical Instruments & Supplies9th of 51 by relative strength

All 51 →
Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#StockStageRS1M
1PLSEStage 2 · wk 3498+1.3%
2PDEXStage 2 · wk 3697−13.3%
3HBIOStage 2 · wk 1195+3.6%
4ATRCStage 2 · wk 1089−1.1%
5WSTStage 2 · wk 2482+4.8%
6BDXStage 2 · wk 1181+9.8%
7ICUIStage 3 · wk 181+3.1%
8OSURStage 3 · wk 875−4.8%
9UTMDStage 2 · wk 3874+0.1%
vs 52W High
-2.1%
$52.78 lo$76.66 hi
2.1% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 38
1w13w26w
Week 38, mature
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
11.6%
200 DMA: $67.24 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.93x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+0.1%
3M
+12.3%
6M
+11.6%
YTD
+34.7%
1Y
+26.6%
Scan Membership
Breakout Watch
Latest: 2023-04-13
6 appearances in last 60 days. First seen: 2019-08-09.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 38 · Vol 1.93x
2026-10-21S2
Wk 38 · Vol 0.87x
2026-10-20S2
Wk 37 · Vol 1.10x
2026-10-19S2
Wk 37 · Vol 0.62x
2026-10-16S2
Wk 37 · Vol 1.25x
2026-10-15S2
Wk 37 · Vol 1.15x
2026-10-14S2
Wk 37 · Vol 0.64x
2026-10-13S2
Wk 36 · Vol 1.10x
2026-10-12S2
Wk 36 · Vol 1.80x
2026-10-09S2
Wk 36 · Vol 1.35x
2026-10-08S2
Wk 36 · Vol 0.97x
2026-10-07S2
Wk 36 · Vol 2.01x
Moving averages & range
50 DMA
$72.84
200 DMA
$67.24
52W High
$76.66
52W Low
$52.78
5D Low
$74.51
Resistance levels (recent highs)
20d High
$75.07
60d High
$76.66
120d High
$76.66
250d High
$76.66
Next resistance
+0.0%
to 20d High
P/E (TTM)
22.9
Forward —
Earnings Growth (YoY)
-10.5%
Revenue -14.3%
ROE
+8.8%
Profit margin +29.0%
Dividend Yield
1.66%
P/B 2.0

Utah Medical Products: quick answers

What stage is Utah Medical Products in?

As of Oct 22, 2026, Utah Medical Products (UTMD) is in Stage 2, the uptrend phase. It entered Stage 2 on Jan 27, 2026 and is in week 38. What the four stages mean

Is Utah Medical Products in an uptrend?

Yes. Utah Medical Products is in a Stage 2 uptrend. It trades 11.6% above its 200-day average, which is rising.

How far is Utah Medical Products from its 52-week high?

Utah Medical Products closed at $75.06 on Oct 22, 2026, 2.1% below its 52-week high of $76.66. Its 52-week low is $52.78.

How has Utah Medical Products performed over the past year?

As of Oct 22, 2026, Utah Medical Products is up 26.6% over the past year and up 34.7% so far in 2026.

Which sector and industry is Utah Medical Products in?

Utah Medical Products is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.